KESIMPTA (ofatumumab)

HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content

0 Members and 0 Guests are viewing this board.

A

(Abst.) Ofatumumab and enteroviral encephalitis: A severe infectious complication...

Started by agate

0Replies

103Views

A

agate May 13

A

(Abst.) Real-world safety and effectiveness of ofatumumab in MS:...

Started by agate

0Replies

142Views

A

agate Mar 6

A

T lymphopenia in MS patients treated with ofatumumab

Started by agate

0Replies

113Views

A

agate Jan 4

A

(Abst.) 6-year safety and efficacy outcomes w/first-line ofatumumab in recently diagnosed pts. w/relapsing MS

Started by agate

0Replies

130Views

A

agate Dec 12, 2025

A

(Abst.) Association of body mass index and clinical response in MS patients receiving ofatumumab

Started by agate

0Replies

229Views

A

agate Mar 7, 2025

A

(Abst.) Ofatumumab-associated colitis: A case report

Started by agate

0Replies

170Views

A

agate Feb 2, 2025

A

(Abst.) IV ofatumumab treatment of MS and related disorders...

Started by agate

0Replies

302Views

A

agate Oct 25, 2022

A

(Abst.) Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive MS patients

Started by agate

0Replies

264Views

A

agate Jul 25, 2022

A

Ofatumumab

Started by agate

8Replies

1253Views

A

agate Aug 21, 2020